278 related articles for article (PubMed ID: 22146975)
21. Percutaneous endovascular Y-stenting of a malignant superior vena cava and innominate vein obstruction.
Cordial R; Moussavian MR; Corvalan J; Görtz H; Teßarek J
Vasc Endovascular Surg; 2014 Jan; 48(1):77-9. PubMed ID: 24122722
[TBL] [Abstract][Full Text] [Related]
22. Sequential treatment of superior vena cava syndrome caused by of non-small cell carcinoma lung cancer (NSCLC) with vascular stenting and iodine-125 implantation.
Xiao L; Li Z; Wu L; Sun Z; Yu X
Technol Cancer Res Treat; 2009 Aug; 8(4):281-7. PubMed ID: 19645521
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous stenting of superior vena cava syndrome: treatment outcome in patients with benign and malignant etiology.
Barshes NR; Annambhotla S; El Sayed HF; Huynh TT; Kougias P; Dardik A; Lin PH
Vascular; 2007; 15(5):314-21. PubMed ID: 17976332
[TBL] [Abstract][Full Text] [Related]
24. Benign superior vena cava syndrome: stenting is now the first line of treatment.
Rizvi AZ; Kalra M; Bjarnason H; Bower TC; Schleck C; Gloviczki P
J Vasc Surg; 2008 Feb; 47(2):372-80. PubMed ID: 18241760
[TBL] [Abstract][Full Text] [Related]
25. Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions.
Bornak A; Wicky S; Ris HB; Probst H; Milesi I; Corpataux JM
Eur Radiol; 2003 May; 13(5):950-6. PubMed ID: 12695814
[TBL] [Abstract][Full Text] [Related]
26. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents.
Gwon DI; Ko GY; Kim JH; Shin JH; Yoon HK; Sung KB
Radiology; 2013 Mar; 266(3):979-87. PubMed ID: 23249571
[TBL] [Abstract][Full Text] [Related]
27. Endovascular treatment for superior vena cava occlusion or obstruction in a pediatric and young adult population: a 22-year experience.
Tzifa A; Marshall AC; McElhinney DB; Lock JE; Geggel RL
J Am Coll Cardiol; 2007 Mar; 49(9):1003-9. PubMed ID: 17336725
[TBL] [Abstract][Full Text] [Related]
28. Long-term results of endovascular stent placement in the superior caval venous system.
Smayra T; Otal P; Chabbert V; Chemla P; Romero M; Joffre F; Rousseau H
Cardiovasc Intervent Radiol; 2001; 24(6):388-94. PubMed ID: 11907745
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous stenting of superior vena cava syndrome: a case report and review of the literature.
Hochrein J; Bashore TM; O'Laughlin MP; Harrison JK
Am J Med; 1998 Jan; 104(1):78-84. PubMed ID: 9528723
[TBL] [Abstract][Full Text] [Related]
30. Single center experience with percutaneous endovascular repair of superior vena cava syndrome.
Canales JF; Cardenas JC; Dougherty K; Krajcer Z
Catheter Cardiovasc Interv; 2011 Apr; 77(5):733-9. PubMed ID: 21061246
[TBL] [Abstract][Full Text] [Related]
31. Gianturco-Rösch expandable Z-stents in the treatment of superior vena cava syndrome.
Rösch J; Uchida BT; Hall LD; Antonovic R; Petersen BD; Ivancev K; Barton RE; Keller FS
Cardiovasc Intervent Radiol; 1992; 15(5):319-27. PubMed ID: 1423393
[TBL] [Abstract][Full Text] [Related]
32. Small cell lung cancer with and without superior vena cava syndrome: a multivariate analysis of prognostic factors in 408 cases.
Würschmidt F; Bünemann H; Heilmann HP
Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):77-82. PubMed ID: 7642434
[TBL] [Abstract][Full Text] [Related]
33. Gianturco expandable wire stents in the treatment of superior vena cava syndrome recurring after maximum-tolerance radiation.
Rösch J; Bedell JE; Putnam J; Antonovic R; Uchida B
Cancer; 1987 Sep; 60(6):1243-6. PubMed ID: 3621110
[TBL] [Abstract][Full Text] [Related]
34. Superior vena cava syndrome associated with massive thrombosis: treatment with expandable wire stents.
Putnam JS; Uchida BT; Antonovic R; Rösch J
Radiology; 1988 Jun; 167(3):727-8. PubMed ID: 3363130
[TBL] [Abstract][Full Text] [Related]
35. Large-bore nitinol stents for malignant superior vena cava syndrome: factors influencing outcome.
Maleux G; Gillardin P; Fieuws S; Heye S; Vaninbroukx J; Nackaerts K
AJR Am J Roentgenol; 2013 Sep; 201(3):667-74. PubMed ID: 23971462
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients.
Bakken AM; Protack CD; Saad WE; Lee DE; Waldman DL; Davies MG
J Vasc Surg; 2007 Apr; 45(4):776-83. PubMed ID: 17398386
[TBL] [Abstract][Full Text] [Related]
37. Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndrome.
Ratzon R; Tamir S; Friehmann T; Livneh N; Dudnik E; Rozental A; Hamburger-Avnery O; Pereg D; Derazne E; Brenner B; Raanani P; Ten Cate H; Spectre G; Leader A
J Thromb Thrombolysis; 2019 Jan; 47(1):121-128. PubMed ID: 30255420
[TBL] [Abstract][Full Text] [Related]
38. Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.
Anton S; Oechtering T; Stahlberg E; Jacob F; Kleemann M; Barkhausen J; Goltz JP
Support Care Cancer; 2018 Jun; 26(6):1881-1888. PubMed ID: 29274029
[TBL] [Abstract][Full Text] [Related]
39. Stenting in malignant obstruction of superior vena cava.
Shah R; Sabanathan S; Lowe RA; Mearns AJ
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):335-40. PubMed ID: 8751500
[TBL] [Abstract][Full Text] [Related]
40. The role of stenting the superior vena cava syndrome in patients with malignant disease.
Cho TH; Janho K; Mohan IV
Angiology; 2011 Apr; 62(3):248-52. PubMed ID: 20834024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
